SOUTH SAN FRANCISCO, Calif.
/PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that it will hold a conference call on
Monday, May 10, 2010
to discuss the Company's first quarter 2010 financial results and provide a corporate update.
Ronald A. Martell
, chief executive officer,
Michael S. Perry
, president and chief medical officer, and
, senior vice president and chief financial officer, will host the call beginning at
4:30 p.m. Eastern Time
1:30 p.m. Pacific Time
). A press release for the first quarter ended
March 31, 2010
, will be released prior to the conference call on
May 10, 2010
To participate in the live call by telephone, please dial 866-700-0133 (
) or 617-213-8831 (International). The passcode for the conference call is 65089280. In addition, the live conference call is being Webcast and can be accessed on the "Events" page of the "News & Events" section of the Company's Web site at
. A replay of the Webcast will be available on the Company's Web site for 10 days.
About Poniard Pharmaceuticals
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit
SOURCE Poniard Pharmaceuticals, Inc.